Detalhe da pesquisa
1.
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis.
Haematologica
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426279
2.
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Ann Hematol
; 103(1): 5-15, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804344
3.
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
Eur J Haematol
; 112(3): 379-391, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899734
4.
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
Ann Hematol
; 102(11): 2979-2988, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668788
5.
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
Eur Respir J
; 59(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446469
6.
Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.
Vox Sang
; 117(2): 259-267, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374093
7.
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.
Future Oncol
; 18(27): 2987-2997, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950489
8.
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.
Ann Hematol
; 100(7): 1723-1732, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942128
9.
Recanalization of portal axis after cavoportal hemitransposition in a liver transplant recipient with complete splanchnic thrombosis.
Pediatr Transplant
; 25(8): e14097, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289227
10.
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.
Haematologica
; 109(2): 676-681, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259556
11.
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
Ann Hematol
; 98(6): 1421-1426, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919072
12.
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Acta Haematol
; 142(4): 197-207, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31163431
13.
Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion.
Br J Haematol
; 202(1): e7-e10, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129059
14.
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial.
Ann Hematol
; 97(9): 1591-1600, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804268
15.
Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel.
Eur J Haematol
; 101(6): 737-749, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171728
16.
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey.
Eur J Haematol
; 100(4): 361-366, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285836
17.
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.
Lancet Oncol
; 18(1): 88-99, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916398
18.
The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer.
Haematologica
; 102(4): 695-706, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082341
19.
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
Haematologica
; 102(9): 1605-1616, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28659337
20.
A haemovigilance team provides both significant financial and quality benefits in a University Hospital.
Transfus Apher Sci
; 56(2): 199-205, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027853